Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-025286
Filing Date
2025-08-25
Accepted
2025-08-22 18:09:05
Documents
22

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 278116
2 EX-5.1 ex5-1.htm EX-5.1 15733
3 EX-10.1 ex10-1.htm EX-10.1 120069
4 EX-23.1 ex23-1.htm EX-23.1 3693
5 EX-23.2 ex23-2.htm EX-23.2 756
6 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 39841
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2895
8 GRAPHIC ex10-1_001.jpg GRAPHIC 708907
9 GRAPHIC ex10-1_002.jpg GRAPHIC 147603
10 GRAPHIC ex10-1_003.jpg GRAPHIC 108946
11 GRAPHIC logo_001.jpg GRAPHIC 10234
12 GRAPHIC ex23-2_001.jpg GRAPHIC 195234
  Complete submission text file 0001641172-25-025286.txt   2199070

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 4992
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289824 | Film No.: 251247380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)